Advertisement
UK markets closed

  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     

  • HANG SENG

    16,828.93
    +317.24 (+1.92%)
     

  • CRUDE OIL

    83.12
    +1.22 (+1.49%)
     

  • GOLD FUTURES

    2,341.10
    -5.30 (-0.23%)
     

  • DOW

    38,527.00
    +287.02 (+0.75%)
     

  • Bitcoin GBP

    53,551.35
    +0.70 (+0.00%)
     

  • CMC Crypto 200

    1,434.24
    +19.48 (+1.38%)
     

  • NASDAQ Composite

    15,687.87
    +236.57 (+1.53%)
     

  • UK FTSE All Share

    4,378.75
    +16.15 (+0.37%)
     
Money:

What is the true cost of the UK state pension?

To get a sense of the true value of the state pension, you can look at how much you would need to save to match it yourself

AstraZeneca reports positive results for COPD drug

Reuters - UK Focus

Sept 25 (Reuters) - AstraZeneca (NYSE: AZN - news) said it had attained positive top-line results in a trial for bronchodilator inhalation aerosol medicine for treatment of patients with moderate to very severe chronic obstructive pulmonary disease (COPD).

AstraZeneca will make regulatory filing applications for the medicine, Bevespi Aerosphere, in Japan and China in 2018, it said on Monday.

The U.S. Food & Drug Administration approved the medicine in April 2016. (Reporting by Rahul B in Bengaluru; editing by Jason Neely)